World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
111
Citations
44338
World Ranking
5344
National Ranking
2885

Ahmet Dogan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ahmet Dogan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 855 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ahmet Dogan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ahmet Dogan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 111 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ahmet Dogan is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research focuses primarily within the field of Medicine, with significant contributions in specialized subfields such as Pathology and Forensic Medicine, Oncology, Genetics, Hematology, and Molecular Biology.

The main topics of their work cover a range of hematologic and oncologic disorders including Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Multiple Myeloma Research and Treatments, Cancer Genomics and Diagnostics, CAR-T Cell Therapy Research, Viral-associated Cancers and Disorders, and Acute Myeloid Leukemia Research.

Ahmet Dogan has frequently published in several prominent scientific journals. These publication venues include Blood, Haematologica, Hematological Oncology, bioRxiv (Cold Spring Harbor Laboratory), and Blood Advances.

The scientist has collaborated extensively with various coauthors across their research projects. Frequent coauthors include Gilles Salles, Mikhail Roshal, Steven M. Horwitz, Andrew D. Zelenetz, and Maria E. Arcila.

Some of the recent papers authored or coauthored by Ahmet Dogan are:

  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee (2022, Blood)
  • GPRC5D-Targeted CAR T Cells for Myeloma (2022, New England Journal of Medicine)
  • Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer (2023, Cancer Discovery)
  • Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants (2020, Journal of Plastic Reconstructive & Aesthetic Surgery)
  • Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma (2021, Journal of Clinical Oncology)

Best Publications

  • Immunoproliferative small-intestinal disease. An immunohistochemical study.

    Peter G. Isaacson;Ahmet Dogan;Stephen K. Price;Jo Spencer

  • The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

    S Bamford;E Dawson;S Forbes;J Clements

  • Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

    Jens G. Lohr;Petar Stojanov;Petar Stojanov;Michael S. Lawrence;Daniel Auclair

  • Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.

    Julie A. Vrana;Jeffrey D. Gamez;Benjamin J. Madden;Jason D. Theis

  • International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

    David C. Fajgenbaum;Thomas S. Uldrick;Adam Bagg;Dale Frank

  • Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy

    Hongxiang Liu;Agnes Ruskon-Fourmestraux;Anne Lavergne-Slove;Hongtao Ye

  • T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.

    Hongxiang Liu;Hongtao Ye;Agnes RuskoneFourmestraux;Daphne De Jong

  • ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

    Edgardo R. Parrilla Castellar;Elaine S. Jaffe;Jonathan W. Said;Steven H. Swerdlow

  • Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

    Eli L. Diamond;Benjamin H. Durham;Julien Haroche;Zhan Yao

  • CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.

    Ahmet Dogan;Eniko Bagdi;Philippa Munson;Peter G. Isaacson

  • Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.

    Selma F. Mohammed;Sultan A. Mirzoyev;William D. Edwards;Ahmet Dogan

  • Angioimmunoblastic T‐cell lymphoma

    Ahmet Dogan;Ayoma D. Attygalle;Chara Kyriakou

  • Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10

    Ayoma Attygalle;Rajai Al-Jehani;Tim C. Diss;Phillipa Munson

  • Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma

    Hongtao Ye;Hongxiang Liu;Ayoma Attygalle;Andrew C. Wotherspoon

  • C3 glomerulonephritis: Clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up

    Sanjeev Sethi;Fernando C. Fervenza;Yuzhou Zhang;Ladan Zand

  • Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.

    Christian Grommes;Christian Grommes;Alessandro Pastore;Nicolaos Palaskas;Sarah S Tang

  • T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10

    Hongxiang Liu;Hongtao Ye;Ahmet Dogan;Renzo Ranaldi

  • HIV infection and lymphoma

    K. L. Grogg;R. F. Miller;R. F. Miller;Ahmet Dogan

  • Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

    Andrew L. Feldman;Ahmet Dogan;David I. Smith;Mark E. Law

  • t(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H-pylori eradication.

    HX Liu;HT Ye;A Ruskone-Fourmestraux;D de Jong

Frequent Co-Authors

Thomas E. Witzig
Thomas E. Witzig Mayo Clinic
James R. Cerhan
James R. Cerhan Mayo Clinic
Susan L. Slager
Susan L. Slager Mayo Clinic
Anne J. Novak
Anne J. Novak Mayo Clinic
Paul J. Kurtin
Paul J. Kurtin Mayo Clinic
Maria E. Arcila
Maria E. Arcila Memorial Sloan Kettering Cancer Center
Peter G. Isaacson
Peter G. Isaacson University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine opens doors to a variety of rewarding online pathways beyond becoming a doctor. Professionals interested in the leadership side of healthcare may consider healthcare administration degree programs, which focus on managing hospitals and health organizations. Evaluating options is key—learn more about how to evaluate healthcare administration degree programs to ensure you choose accredited and respected programs.

For nurses aiming to advance their careers, an asn to fnp program is a popular bridge to become a Family Nurse Practitioner, opening doors to advanced clinical roles and higher earning potential.

Those passionate about wellness and science may want to pursue an online degree in nutrition. This pathway prepares graduates for diverse careers, from clinical nutrition to public health and research.

Online degrees provide flexibility, accessibility, and tailored specializations—perfect for those balancing education with work or family commitments. Consider your goals, compare programs, and choose a path that aligns with your ambitions in the healthcare field.

Best Scientists Citing Ahmet Dogan

Trending Scientists

Recently Published Articles